EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biochemical Characteristics, Treatment, and Outcomes of Thyrotoxicosis in Amiodarone-Treated Individuals with Prior Hypothyroidism

Afif Nakhleh iD, Limor Adler, Shirley Shapiro Ben David, Daniella Rahamim-Cohen, Ori Liran, Sagit Zolotov

Endocrine Connections · 12.11.2026

DOI: 10.1530/ec-26-0539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Connections, online erschienen am 12.11.2026. Verfasst von Afif Nakhleh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Endocrinology Clinic, Maccabi Healthcare Services , Haifa, Israel. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence regarding the transition from hypothyroidism to thyrotoxicosis in amiodarone-treated patients remains scarce. We compared clinical characteristics, treatments, and outcomes of amiodarone-exposed individuals developing thyrotoxicosis following hypothyroidism (post-hypo-T) versus those without prior thyroid disease (T-controls).

Methods

This retrospective cohort study utilized electronic health records from a large health maintenance organization (HMO). We included adults from the cardiovascular disease registry with new-onset thyrotoxicosis diagnosed between January 1, 2010, and December 31, 2022, who received amiodarone within the year preceding diagnosis. Follow-up ended on August 31, 2025. Cox regression models adjusted for age and sex were used to analyze outcomes.

Results

Of 558 individuals, 91 (16%) had prior hypothyroidism and 467 were controls. Post-hypo-T patients were older (70.4±10.1 vs. 67.4±11.0 years; p = 0.02) and had a higher proportion of males (44.0% vs. 25.3%; p < 0.001). Median amiodarone exposure prior to diagnosis was 2.7 versus 2.8 years, respectively (p = 0.01). At diagnosis, post-hypo-T individuals had lower median free thyroxine (fT4) levels (27.0 vs. 31.3 pmol/L; p < 0.001) and free triiodothyronine (fT3) levels (6.4 vs. 7.5 pmol/L; p < 0.001). Over a 7.8-year median follow-up, antithyroid medications were used less frequently in post-hypo-T individuals (37.4% vs. 54.0%; p = 0.004). Glucocorticoid use was numerically lower in post-hypo-T individuals (26.4% vs. 38.5%; p = 0.06). Post-hypo-T individuals had a higher incidence of hypothyroidism requiring levothyroxine (64.8% vs. 17.8%; p < 0.001).

Conclusions

Among amiodarone-exposed individuals who develop thyrotoxicosis, those with prior hypothyroidism have a milder biochemical presentation, less frequent use of antithyroid drugs or glucocorticoids, and a higher likelihood of recurrent hypothyroidism requiring levothyroxine.

Schlagwörter

Stichwörter der Autor:innen

Amiodaroneantithyroid drugsglucocorticoidshypothyroidismlevothyroxinethyrotoxicosis

Autor:innen und Institutionen

  • Diabetes and Endocrinology Clinic, Maccabi Healthcare Services , Haifa, Israel.
  • Institute of Endocrinology, Diabetes and Metabolism, Rambam Health Care Campus , Haifa, Israel.
  • Azrieli Faculty of Medicine, Bar-Ilan University , Safed, Israel.
  • Health Division, Maccabi Healthcare Services , Tel Aviv, Israel.
  • Faculty of Medicine, Tel Aviv University , Israel.

ORCID-Profile: Afif Nakhleh

Zitieren

APA

Nakhleh, A., Adler, L., Ben David, S. S., Rahamim-Cohen, D., Liran, O., & Zolotov, S. (2026). Biochemical Characteristics, Treatment, and Outcomes of Thyrotoxicosis in Amiodarone-Treated Individuals with Prior Hypothyroidism. Endocrine Connections. https://doi.org/10.1530/ec-26-0539

Vancouver

Nakhleh A, Adler L, Ben David SS, Rahamim-Cohen D, Liran O, Zolotov S. Biochemical Characteristics, Treatment, and Outcomes of Thyrotoxicosis in Amiodarone-Treated Individuals with Prior Hypothyroidism. Endocrine Connections. 2026. doi:10.1530/ec-26-0539

BibTeX
@article{Nakhleh2026,
  author = {Nakhleh, Afif and Adler, Limor and Ben David, Shirley Shapiro and Rahamim-Cohen, Daniella and Liran, Ori and Zolotov, Sagit},
  title = {Biochemical Characteristics, Treatment, and Outcomes of Thyrotoxicosis in Amiodarone-Treated Individuals with Prior Hypothyroidism},
  journal = {Endocrine Connections},
  year = {2026},
  doi = {10.1530/ec-26-0539}
}
Kostenlos starten →